
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is expected to see a boost in sales with new products and focus on innovation and recurring revenue. Despite facing competition and slow margin expansion, the company's commitment to sustainability and correlation between backlog growth and revenue make it well-positioned for future success. With a diverse portfolio and expansion into new markets, GE HealthCare Techs is a strong contender in the medical technology industry, and their investments in AI and digital solutions can further drive growth and profitability.
Bears say
GE HealthCare Techs is facing strong competition in the medical technology market, as well as macroeconomic challenges and regulatory scrutiny. While their strategic shift towards mobile and cable-free interventional systems has been praised, there is a risk of delays or challenges in new product launches. Revenue growth is highly correlated to backlog and orders, but M&A activity and trade dynamics also present risks. The company's BTB ratio and organ
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares